Hospiten News

Check the latest news

Dr. Rafael Llorens Leon, receives the ‘Pasteur Prize for Medicine, Pharmacy and Biomedical Research 2021’

Dr. Rafael Llorens Leon, receives the ‘Pasteur Prize for Medicine, Pharmacy and Biomedical Research 2021’
Posted on 21-12-2021

These prizes, awarded by the European Society for Social and Cultural Promotion, reward the commitment of the world of science, medicine and research with society.

The Hospiten Group receives recognition from the Official College of Pharmacists for their collaboration in the management of the vaccination of pharmacists

The Hospiten Group receives recognition from the Official College of Pharmacists for their collaboration in the management of the vaccination of pharmacists
Posted on 20-12-2021

At this edition, tribute was paid to individuals or institutions that have worked closely with the Official College of Pharmacists (COF) of Santa Cruz de Tenerife in the development of their welfare and social work.

La doctora Natalia Carballo elegida Embajadora de la ciudad de Madrid por la Oficina de Turismo del Ayuntamiento de la capital

La doctora Natalia Carballo elegida Embajadora de la ciudad de Madrid por la Oficina de Turismo del Ayuntamiento de la capital
Posted on 16-12-2021

La doctora Natalia Carballo, jefa del Servicio de Radioterapia de MD Anderson Cancer Center Madrid y miembro de la Sociedad Española de Oncología Radioterápica (SEOR), ha sido elegida como una de las Embajadoras de la ciudad de Madrid en el Acto de Homenaje “Recognition Night”...

Hospiten stresses the importance of an early diagnosis of polycystic ovary syndrome

Hospiten stresses the importance of an early diagnosis of polycystic ovary syndrome
Posted on 07-12-2021

It is one of the most common endocrine problems in women and the most common cause of infertility.

Medicine and mathematics, there cannot be one without the other

Medicine and mathematics, there cannot be one without the other
Posted on 07-12-2021

The ‘Canarias Masterclass’ corporate social responsibility project is an initiative of the Canary Talent Association which seeks to support the talent of Canary students, bringing them closer to the reality of the labor market.

Hospiten Roca recognized for its excellence in quality

Hospiten Roca recognized for its excellence in quality
Posted on 18-11-2021

The Group's centers in San Agustin and Vecindario renew and improve the QH accreditation granted by the IDIS Foundation

Hospiten es el centro de referencia sanitario para la VII carrera BTT Manilva

Hospiten es el centro de referencia sanitario para la VII carrera BTT Manilva
Posted on 17-11-2021

El Club Ciclista Manilva conjuntamente con el Ayuntamiento de la localidad han elegido a Hospiten, centro de referencia en cardiología y traumatología deportiva, para atender a los posibles lesionados o heridos que pueda haber durante la carrera, y dotar de más seguridad al evento deportivo.

Hospiten Roca gynecologist wins grant to research fetal heart failure

Hospiten Roca gynecologist wins grant to research fetal heart failure
Posted on 11-11-2021

Dr. Anna Erenbourg explains that the objective is to establish a predictive model that allows possible anomalies to be identified in time and ensure a full-term pregnancy
 

Endoscopic spine surgery: a success story at Hospiten Estepona

Endoscopic spine surgery: a success story at Hospiten Estepona
Posted on 11-11-2021

The future of spinal operations is a reality at Hospiten Estepona, where the first procedures using this advanced technique have already been carried out. The results: interventions with minimum harm to the patient, discharge in just 12 hours and a considerably shorter recovery time than with the conventional procedure

MD Anderson Madrid inaugurates their Phase I Clinical Trials Unit, one of the largest in Spain and Europe dedicated to the first phase of research

MD Anderson Madrid inaugurates their Phase I Clinical Trials Unit, one of the largest in Spain and Europe dedicated to the first phase of research
Posted on 03-11-2021

Advised directly from Houston, the unit will focus on research into the most promising cancer drugs in clinical development worldwide. It is estimated that more than 40 clinical studies in phase I will be investigated simultaneously.